Don't kill the patient before he dies.

In oncology practice, the pursuit of life-prolonging treatments often raises critical ethical and clinical questions about the balance between aggressive interventions and the preservation of quality of life. As cancer therapies continue to advance, there is an increasing risk of over-treatment, where the focus on extending life may inadvertently compromise a patient's comfort, dignity, and overall well-being. This article explores the concept of "Do Not Kill the Patient before He Dies," urging oncologists to adopt a patient-centered approach that prioritizes thoughtful decision-making and individualized care. This article examines the challenges of navigating the fine line between curative and palliative intents, particularly in advanced-stage cancer, where the benefits of treatment may diminish relative to its side effects. The article highlights the consequences of over-treatment, drawing on case studies, patient narratives, and evidence-based research to illustrate how aggressive interventions can lead to physical, emotional, and financial burdens for patients and their families. Key strategies to mitigate these risks are discussed, including the role of shared decision-making, honest communication about prognosis and treatment goals, and the timely integration of palliative care. By fostering a culture of empathy, collaboration, and respect for patient autonomy, oncology practitioners can ensure that therapeutic choices align with the values and priorities of those they serve. This article advocates for a paradigm shift in oncology, emphasizing the importance of not just prolonging life but enhancing its quality.